Ginsenoside Rg5, CAS [[186763-78-0]]

Produktübersicht

• Artikelname: Ginsenoside Rg5, CAS [[186763-78-0]]
• Artikelnummer: TGM-T6S1487
• Hersteller Artikelnummer: T6S1487
• Alternativnummer: TGM-T6S1487-1MLX10MM(INDMSO),TGM-T6S1487-1MG,TGM-T6S1487-5MG,TGM-T6S1487-10MG,TGM-T6S1487-25MG,TGM-T6S1487-50MG,TGM-T6S1487-100MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien

Produktbeschreibung

1. Ginsenoside Rg5 could be a beneficial agent for the treatment of Alzheimers disease. 2. Ginsenoside Rg5 suppresses LPS-induced nitric oxide (NO) production and proinflammatory TNF-alpha secretion. 3. Ginsenoside Rg5 can ameliorate lung inflammation possibly by inhibiting the binding of LPS to toll-like receptor (TLR)-4 on macrophages. 4. Ginsenoside Rg5 plays a novel role as an IGF-1R agonist, promoting therapeutic angiogenesis and improving hypertension without adverse effects in the vasculature. 5. Ginsenoside Rg5 blocks cell cycle of SK-HEP-1 cells at the Gl/S transition phase by down-regulating cyclin E-dependent kinase activity and that the down-regulation of cyclin E-dependent kinase activity is caused mainly by induced CDK2 inhibitor, p21Cip/WAF1 and decreased levels of cyclin E.

Produkteigenschaften

• Molekulargewicht: 767
• Reinheit: 98.00%
• CAS Nummer: [186763-78-0]
• Formel: C42H70O12
• Target-Kategorie: COX|||NF-kappaB|||IGF-1R

Bilder

T6S1487